Two Cases of High Tibial Osteotomy in Patients with Rheumatoid Arthritis Treated with Biologic Disease-modifying Anti-rheumatic Drugs by Takahara, Yasuhiro et al.
S ince the 15 years after the introduction of biologic disease-modifying anti-rheumatic drugs (bDMARDs) 
for clinical application in Japan,  the bDMARDs have 
shown promising clinical effects against the disease 
activity of rheumatoid arthritis (RA) [1].  In addition to 
a dramatic suppression of synovial inflammation,  
bDMARDs have been demonstrated to prevent joint 
destruction and to achieve a structural repair of the 
joint in some patient populations.  However,  even 
under good disease control by bDMARDs,  some 
patients show continuous inflammation of a specific 
joint,  and other patients might already have joint 
destruction with irreversible functional impairments 
[2].  Even after the amelioration of synovial inflamma-
tion by a bDMARD,  joints with hyaline cartilage wear 
can undergo osteoarthritic changes including osteo-
phyte formation,  which can be a cause of joint pain and 
a restricted range of motion [3].
The high tibial osteotomy (HTO) procedure has been 
widely accepted for medial knee osteoarthritis (OA) 
since Coventry first reported favorable outcomes in 
1979 [4].  A few later modifications including open-
wedge HTO (OWHTO) [5 , 6] and lateral closed-wedge 
HTO (hybrid CWHTO) [7] have contributed to the 
shortening of the post-operative rehabilitation period.  
HTO has been contraindicated in patients with RA 
because poor disease control may lead to a post-opera-
tive exacerbation of joint deterioration.  However,  when 
the patients are appropriately selected,  joint-preserving 
surgery of the knee joint might be beneficial.  Herein we 
report our experiences with two patients who under-
went HTO and whose RA activity was controlled by 
bDMARDs.  These cases demonstrate that a combina-
tion therapy of orthopedic surgery and medical treat-
ment can be beneficial for the preservation of the rele-
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High tibial osteotomy (HTO) procedure is generally contraindicated in rheumatoid arthritis (RA) patients 
because synovial inflammation may exacerbate joint damage post-surgery.  The natural course of joint destruc-
tion in RA changed dramatically with new treatment strategies and the introduction of biologic disease-modi-
fying anti-rheumatic drugs (bDMARDs).  We report the cases of two RA patients who underwent HTO and 
whose disease activities were well controlled by bDMARDs.  Despite their short follow-up periods,  they showed 
acceptable objective and subjective clinical results.  We believe that the combination of bDMARDs and HTO can 
be indicated for selected RA patients before total knee arthroplasty.
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vant joints’ structure and function.
Case Reports
Case 1. A 71-year-old Japanese woman (height 
146 cm,  weight 48 kg,  BMI 22.6 kg/m2) had developed 
symptoms of RA at approx.  60 years of age.  There was 
no remarkable past medical history other than the RA.  
She had been treated with infliximab (200 mg/8 weeks) 
from 2006 to 2012 and was first prescribed etanercept 
(50 mg/week) in January 2014 because her condition 
became refractory.  In January 2015,  she began receiv-
ing tocilizumab (400 mg/4 weeks) followed by abatacept 
(500 mg/4 weeks) in December 2015 to address the 
gradual weakening of the effects of previous medications.  
In 2016,  she began receiving methotrexate (MTX,  
10 mg/week),  abatacept (125 mg/week),  and predniso-
lone (PSL,  2.5 mg/day) to maintain disease control of 
the RA.
The rheumatology department referred this patient 
to the orthopedic surgery department because she 
experienced right knee pain and consequent gait diffi- 
culties.  At the initial examination,  her C-reactive protein 
(CRP) level was 0.25 mg/dL,  anti-cyclic citrullinated 
peptide antibody (ACPA) level was 124 U/mL,  rheu-
matoid factor (RF) was 25 U/mL,  and disease activity 
score (DAS)-CRP was 2.8: tender joint count: 1,  swol-
len joint count: 1,  patient’s global assessment of health 
(PtGA) with the visual analogue scale (VAS): 40.  The 
right knee joint range of motion was −5°-120°,  and the 
Japanese Orthopedic Association score (JOA score) was 
80 points.
Radiographic examinations showed narrowing and 
osteophyte formation at the medial joint space of right 
knee.  The joint space was preserved at the patella-fem-
oral joint (Fig. 1).  The mechanical axis (%MA) was 
22%,  the standing femoro-tibial angle (FTA) was 
180.1°,  and the medial proximal tibial angle (MPTA) 
was 84.2°.  An initial arthroscopic assessment revealed 
that the condition of the lateral cartilage was main-
tained despite damage to the medial cartilage on both 
the femoral and tibial condyles,  and there was no syno-
vial proliferation in the knee (Fig. 2).  Consequently,  
treatment for ordinary osteoarthritis (OA) was consid-
ered,  and we performed 10° open-wedge HTO 
(Fig. 3A).  From the day after operation,  the patient 
began range-of-motion (ROM) exercise of the knee and 
walked with 1/3 partial weight bearing (PWB).  She 
could walk with full weight bearing (FWB) within 
4 weeks after the OWHTO.
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???? ?　 Case 1.  Radiograph before operation.  A,  AP; B,  lateral; C,  skyline; D,  Rosenberg view.
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???? ?　 Arthroscopic ﬁndings.  A,  Medial compartment; B,  Lateral 
compartment.  Arrow indicates cartilage loss at the medial femoral 
and tibial condyles; LFC,  lateral femoral condyle; LM,  lateral 
meniscus; LTC,  lateral tibial condyle; MFC,  medial femoral condyle;  
MM,  medial meniscus; MTC,  medial tibial condyle.
At 20 months postoperatively,  the patient exhibited 
ROMs in the right knee joint of 0° during extension and 
135° during flexion while free walking as well as JOA 
score of 90 points.  Successful bone union was achieved,  
and the medial joint space was maintained (Fig. 3B).  
When the plate was removed,  there was no synovial 
proliferation in a second-look arthroscopic assessment.  
We also observed no synovial proliferation by MRI after 
the plate removal (Fig. 3C).  The %MA,  standing FTA,  
and MPTA were 60%,  173.2°,  and 92.0° at the final fol-
low-up.  The patient also exhibited an improved score on 
the Short Form Health Survey (SF-36),  which is used to 
evaluate patients’ satisfaction with their physical and 
mental states (Fig. 4).  Currently,  the patient’s disease 
activity evaluated using DAS28-CRP is 2.4 (tender joint 
count: 1,  swollen joint count: 0,  PtGA: 18,  and CRP:  
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???? ?　 Postoperative radiograph.  A,  Just after operation; B,  One year after operation,  bone union had occurred; C,  MRI after implant 
removal.
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???? ?　 The changes in the patientʼs SF-36 scores from before the operation to 3 and 6 months later.
0.55 mg/dL).
Case 2. A 68-year-old Japanese woman (height 
155 cm,  weight 66 kg,  BMI 27.4 kg/m2) had developed 
RA at approx.  66 years old.  There was no notable past 
medical history other than her RA.  A physician had 
prescribed MTX (4 mg/week) and golimumab (50 mg/ 
4 weeks).  She experienced persistent pain in her left 
knee and was subsequently referred to the department 
of orthopedic surgery at our hospital in August 2016.
At the initial examination,  her CRP level was 
8.4 mg/dL,  ACPA level was 123 U/mL,  RF level was 
22 U/mL,  and DAS28-CRP was 4.3.  As she did not 
desire injections,  she was accordingly prescribed MTX 
(4 mg/week),  golimumab (50 mg/4 weeks),  and PSL 
(5 mg/day).
By January 2017,  the patient’s CRP level was 1.0 mg/dL 
and her disease activity evaluated using the DAS28-CRP 
was 3.1 (tender joint count: 2,  swollen joint count: 0,  
PtGA: 40).  Her left knee had a range of motion of 
−10°-135°,  and her JOA score was 50 points.  Radiographic 
examinations showed narrowing and osteophyte forma-
tion at the medial joint space.  Joint space was preserved 
at the patella-femoral joint (Fig. 5).  The %MA was 25%,  
the standing FTA was 180.2°,  and the MPTA was 85.8°.
An initial arthroscopic assessment revealed cartilage 
loss on the medial femoral and tibial condyles and syno-
vial proliferation at the anterior capsule (Fig. 6),  but the 
condition of the lateral cartilage was maintained.  We 
performed a synovectomy at the anterior capsule and 
suprapatellar pouch,  followed by a 9° hybrid CWHTO 
(Fig. 7A).  From the day after operation,  the patient 
began ROM exercise of the knee and walked with 1/3 
PWB within 1 week.  She could walk with FWB within 
5 weeks after the hybrid CWHTO.
At 21 months postoperatively,  the patient exhibited 
right knee ROMs of 0° during extension and 135° during 
flexion while free walking and a JOA score of 70 points.  
Successful bone union was achieved,  and the medial 
joint space has been maintained (Fig. 7B).  When the 
plate was removed,  there was still synovial proliferation 
at the supra-patellar pouch revealed by a second-look 
arthroscopic assessment.  We also observed some syno-
vial proliferation by MRI after the plate removal (Fig.7C).  
The %MA,  standing FTA,  and MPTA were 61%,  171.6°,  
and 92.2° at the final follow-up.  The patient also exhib-
ited an improved SF-36 score relative to the surveys 
administered preoperatively and at 3 and 6 months 
postoperatively (Fig. 4).  Her disease activity evaluated 
using the DAS28-CRP was 1.6 (CRP: 0.66 mg/dL,  ten-
der joint count: 0,  swollen joint count: 0,  PtGA: 0).
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???? ?　 Case 2.  Radiograph before operation.  A,  AP; B,  lateral; C,  skyline; D,  Rosenberg view.
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???? ?　 Arthroscopic ﬁndings.  A,  Medial compartment.  Arrow 
indicates cartilage loss at the medial femoral and tibial con-
dyles; B,  Synovium proliferation at the anterior capsule; MFC,  
medial femoral condyle; MM,  medial meniscus; MTC,  medial tibial 
condyle.
Discussion
In the past,  the knee surgeries performed for patients 
with RA were largely passive with the use of procedures 
such as artificial joint replacement when the pain became 
difficult to endure and activities of daily living could no 
longer be performed.  However,  if the suppression of 
joint deterioration can be achieved with medication,  
more challenging surgical procedures might be consid-
ered to further improve the function [8].  The paradigm 
of surgical reconstruction of a rheumatoid forefoot,  
which was previously typified by the earlier Lelièvre 
procedure,  has shifted to joint preservation surgery 
[9-11].  We believe that if knee joint deterioration can be 
suppressed by biologic drugs,  clinicians can consider 
joint preservation surgeries that are intended to yield 
more aggressive functional recoveries.
At our institute,  HTO has been indicated for OA 
patients of all ages who exhibit varus limb alignment,  
localized medial compartment lesions,  and knee pain 
persisting after 3 months of conservative treatment.  As 
HTO is a physiological procedure and requires careful 
post-treatment care,  patients indicated for HTO should 
be those who can understand and perform post-opera-
tive rehabilitation and express a desire for joint preser-
vation.  Cases involving infection,  pronounced defor-
mation of the patellofemoral joint,  a femoro-tibial angle 
≥185°,  flexion contracture of ≥20°,  or a restricted range 
of motion of < 90° are contra-indication for an HTO.  
There is no age restriction or BMI restriction among our 
indications for HTO.  It is important for surgeons to 
note that patient education is essential for successful 
postoperative rehabilitation after an HTO.
Very few reports have discussed HTO in patients 
with RA.  Chan et al.  [12] reported the outcomes of HTO 
in 36 patients with RA from postoperative years 1 to 6,  
and they reported that 42%,  19%,  and 38% of the out-
comes could be classified as good,  satisfactory,  and 
poor,  respectively.  Despite these largely favorable results,  
however,  the prevalence of poor cases increased after 
postoperative year 3,  and the performance of HTO for 
RA was reported to be inferior to that of HTO for OA 
symptoms.  Additionally,  Matsushita et al.  [13] reported 
the presence of changes in weight-bearing joints in RA 
patients who received tumor necrosis factor (TNF) 
inhibitors based on X-ray assessments.  In that report,  
the Larsen grade [14] (a measure applied to radiographs 
of RA patients) at treatment initiation and disease activ-
ity 1 year later were shown to influence the progression 
of hip and knee joint deterioration displayed via radio-
graphs.  We therefore believe that the sufficient control 
of RA symptoms is essential when performing HTO 
surgery in the affected patients.
It is also critical to determine whether an HTO is 
indicated for a knee joint at the early stage of joint dete-
rioration.  Considering our 2 patients,  there was no 
synovial proliferation at the initial arthroscopic assess-
ment in Case 1.  We could perform an HTO as OA 
changed knee in RA patients.  In contrast,  There was 
still synovial proliferation in Case 2,  and her JOA score 
and SF-36 improved after the operation but the result 
was not as satisfactory compared to that of Case 1.  An 
HTO can be indicated in patients with RA only when 
the disease activity is controlled through a bDMARD 
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???? ?　 Postoperative radiograph.  A,  Just after operation; B,  One year after operation,  bone union had occurred; C,  MRI after implant 
removal.  There was still synovial proliferation at the supra-patellar pouch.
and a lesion originating from medial knee OA is identi-
fied through radiographic examinations.  The absence of 
synovial proliferation is the key to achieve satisfactory 
results of an HTO for an RA patient.
Surgeons should aim for better surgical outcomes and 
functional improvement for highly demanded patients 
with better disease control by biologic DMARDs.  In 
recent years,  reports have described a fairly low level of 
patient satisfaction following total knee arthroplasty 
(TKA) [15].  In the present cases,  the SF-36 was used to 
evaluate the patients’ stance type,  and it also demon-
strated improvements in mental and physical items.  
Although we have presented the cases of only 2 patients 
with short postoperative observation periods,  we 
believe that the HTO as a joint-preservation surgery 
procedure will yield further functional improvements in 
patients with RA.
References
 1. Takabayashi K,  Ando F and Suzuki T: Comparing the eﬀectiveness 
of biological disease-modifying antirheumatic drugs using real-world 
data.  Mod Rheumatol (2019) 29: 87-97.
 2. Ishida M,  Kuroiwa Y,  Yoshida E,  Sato M,  Krupa D,  Henry N,  Ikeda K 
and Kaneko Y: Residual symptoms and disease burden among 
patients with rheumatoid arthritis in remission or low disease activity:  
a systematic literature review.  Mod Rheumatol (2018) 28: 789-799.
 3. Ozaki T,  Hashizume K,  Nakahara R and Nishida K: Radiographic 
remodeling of the shoulder joint in a patient with rheumatoid arthritis 
after 4 years of treatment with etanercept.  Mod Rheumatol (2012) 
22: 735-637.
 4. Coventry MB: Upper tibial osteotomy for gonarthrosis.  The evolution 
of the operation in the last 18 years and long term results.  Orhop Clin 
North Am (1979) 10: 191-210.
 5. Lobenhoﬀer P and Agneskirchner JD: Improvements in surgical 
technique of valgus high tibial osteotomy.  Knee Surg Sports Traumatol 
Arthrosc (2003) 11: 132-138.
 6. Takeuchi R,  Ishikawa H,  Aratake M,  Bito H,  Saito I,  Kumagai K,  
Akamatsu Y and Saito T: Medial opening wedge high tibial osteot-
omy with early full bearing.  Arthroscopy (2009) 25: 46-53.
 7. Takeuchi R,  Ishikawa H,  Miyasaka Y,  Sasaki Y,  Kuniya T and 
Tsukahara S: A novel closed-wedge high tibial osteotomy proce-
dure to treat osteoarthritis of the knee: Hybrid technique and reha-
bilitation measures.  Arthrosc Tech (2014) 3: 431-437.  
 8. Smolen JS,  Aletaha D,  Bijisma JW,  Breedveld FC,  Boumpas D,  
Burmester G,  Combe B,  Cutolo M,  de Wit M,  Dougados M,  
Emery P,  Gibofsky A,  Gomez-Reino JJ,  Haraoui B,  Kalden J,  
Keystone EC,  Kvien TK,  Mclnnes I,  Martin-Mola E,  Montecucco C,  
Schoels M and van der Heijde D; T2T Expert Committee.  Treating 
rheumatoid arthritis to target recommendations of an international 
task force.  Ann Rheum Dis (2010) 69: 631-637.
 9. Hirao M,  Ebina K,  Tsuboi H,  et al: Outcomes of modiﬁed metatar-
sal shortening oﬀset for forefoot deformity in patients with rheuma-
toid arthritis: short to mid-term follow-up.  Mod Rheumatol (2017) 27:  
981-989.
10. Nishida K,  Machida T,  Horita T,  Hashizume K,  Nakahara R,  Nasu Y,  
Ohashi H,  Saiga K and Ozaki T: Shortening oblique osteotomy with 
screw ﬁxation for correction of the lesser metatarsophalangeal joints 
of rheumatoid forefoot.  Acta Med Okayama (2016) 70: 477-483.
11. Horita M,  Nishida K,  Hashizume K,  Nasu Y,  Saiga K,  Nakahara R,  
Machida T,  Ohashi H and Ozaki T: Resection versus joint-preserv-
ing arthroplasty for forefoot deformities in patients with rheumatoid 
arthritis.  Foot & Ankle Int (2018) 39: 292-299.
12. Chan RN and Pollard JP: High tibial osteotomy for rheumatoid arthri-
tis of the knee.  A one to six-year follow-up study.  Acta Orthop Scand 
(1978) 49: 78-84.
13. Matsushita I,  Motomura H,  Seki E and Kimura T: Radiographic 
changes and factors associated with subsequent progression of 
damage in weight-bearing joints of patients with rheumatoid arthritis 
under TNF-blocking therapies-three-year observational study.  Mod 
Rheumatol (2017) 27: 570-575.  
14. Larsen A,  Dale K and Eek M: Radiographic evaluation of rheuma-
toid arthritis and related conditions by standard reference ﬁlms.  
Acta Radiol Diagn (Stockh) (1977) 18: 481-491.
15. Wylde V,  Dieppe P,  Hewlett S and Learmonth ID: Total knee 
replacement: is it really an eﬀective procedure for all? Knee (2007) 
14: 417-423.
542 ??????????????? ????????? ????????????? ???? ???? ??
